JamesSamuelTomlinsonIIIMDPhD

Surgical Oncology (Other than Breast)

Professor, Surgery, UCLA School of Medicine

Dr. Tomlinson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
200 Medical Plaza Suite B265
Los Angeles, CA 90095
Phone+1 310-206-6909

Fax+1 310-794-1699

Dr. James Tomlinson is a general surgeon in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Ronald Reagan UCLA Medical Center and VA Greater Los Angeles Healthcare System. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania, general surgery residency at UCLA and additionally did a fellowship in Surgical Oncology at Memorial-Sloan Kettering Cancer Center. He has been in practice 22 years. He specializes in complex surgical oncology and performs robotic surgery. Dr. Tomlinson also earned a PhD from UCLA and has an active laboratory investigating cancer biology and biomarker development.

University of California, Los AngelesPh.D., Molecular Pathology, 2005 - 2009
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2003 - 2005
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 1995 - 2003
Perelman School of Medicine at the University of PennsylvaniaClass of 1995

PubMed

12 citations
Are 12 Nodes Needed to Accurately Stage T1 and T2 Colon Cancers
Melinda A. Maggard, Irina Yermilov, James S. Tomlinson, Clifford Y. Ko
Digestive Diseases and Sciences. 2009-03-01
10 citations
A systematic review of methodological principles and delivery of surgical simulation bootcamps
Matthew Young, Chris Lewis, Mithun Kailavasan, Lisa Satterthwaite, Oleg Safir
American Journal of Surgery. 2021-11-24
59 citations
Perioperative antibiotics for surgical site infection in pancreaticoduodenectomy: does the SCIP-approved regimen provide adequate coverage?
Graham W. Donald, Dharma Sunjaya, Xuyang Lu, Formosa Chen, Barbara M. Clerkin
Surgery. 2013-08-01

Journal Articles

A Prognostic Scoring System for the Prediction of Metastatic Recurrence Following Curative Resection of Pancreatic Neuroendocrine Tumors
Paul A Toste, Shonan Sho, Colin M Court, Joseph R Pisegna, Oscar J Hines, Howard A Reber, David W Dawson, Michael Lewis, James S Tomlinson, Timothy R Donahue, Journal of gastrointestinal surgery